Advertisement
Technology areas represented will include: novel targets, leads andmolecules, biomarkers, diagnostics, drug development platforms, drug deliverysystems and medical devices. All technologies will be pre-screened byChinaBio(R) to ensure the highest quality presentations and partneringopportunities.
Advertisement
To date, ChinaBio(R)-produced events have helped early and mid-stagebiotech companies in China to access over $60 million US and close partneringdeals with leading pharmaceutical companies including Pfizer, Roche, Lilly andMerck.
"China is the fastest growing market for pharmaceuticals in the world andnow is transforming itself into an internationally-recognized leader inbiotech innovation," said Greg Scott, President and founder of ChinaBio(R)."China biotech is clearly poised for global success because of its significantnumber of highly skilled scientists and innovators coupled with stronggovernment support and a unique low cost, high quality development structure.We are now very pleased to announce our first Partnering Forum to be held inChina and look forward to expanding on the success of our prior events here."
More details on the ChinaBio(R) Partnering Forum are available on thewebsite http://www.CBPF2009.com.
About ChinaBio(R) Accelerator
ChinaBio(R) Accelerator is an operating unit of ChinaBio(R) LLC, which hasoffices in Shanghai, Palo Alto, California, and San Diego, California. Theorganization is committed to furthering opportunities for the emerging Chinesebiotech industry by funding and mentoring early stage China-based life sciencecompanies, and leveraging its established cross-borders life science networkto help companies secure high value partnerships and make the transition tothe global market. For further information: http://www.chinabiollc.comContacts: ChinaBio(R) Accelerator Greg Scott 858.866.9309 [email protected] For ChinaBio(R) Accelerator Jennifer Larson 415.725.2017 [email protected]
SOURCE ChinaBio(R)
